Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18,229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Utilization of Mutational Analysis (MA) in Gastrointestinal Stromal Tumor (GIST) Management in British Columbia (BC) Between January 2008 to December 2017: a Retrospective Population-Based Study.
Patterson T, Chai J, Li H, de Bruyns A, Cleversey C, Lee CH, Yip S, Simmons C, Hart J, Pollock P, Holloway C, Truong P, Feng X. Patterson T, et al. Among authors: feng x. J Gastrointest Cancer. 2022 Sep;53(3):709-717. doi: 10.1007/s12029-021-00682-2. Epub 2021 Sep 6. J Gastrointest Cancer. 2022. PMID: 34486087
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
Peretz Soroka H, Vora T, Noujaim J, Marcoux N, Cohen-Gogo S, Alcindor T, Holloway C, Rodrigues C, Karachiwala H, Alvi S, Lee U, Cheng S, Banerji S, Oberoi S, Feng X, Smrke A, Simmons C, Razak AA, Gupta AA. Peretz Soroka H, et al. Among authors: feng x. Cancer Med. 2023 Sep;12(18):18872-18881. doi: 10.1002/cam4.6515. Epub 2023 Sep 19. Cancer Med. 2023. PMID: 37724607 Free PMC article.
Corrigendum to "Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study" [Eur. J. Cancer, vol. 205 (2024) 114119].
Noujaim J, Gupta AA, Holloway CL, Saleh R, Srikanthan A, Lemieux C, Soroka HP, Tibout P, Turcotte R, Feng X, Abdul Razak AR, Costa P. Noujaim J, et al. Among authors: feng x. Eur J Cancer. 2024 Sep;208:114221. doi: 10.1016/j.ejca.2024.114221. Epub 2024 Jul 8. Eur J Cancer. 2024. PMID: 38981738 Free article. No abstract available.
Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study.
LeVasseur N, Sun J, Fenton D, Baxter S, Chan A, Roberts S, Feng X, Lohrisch C, Gelmon K, Shenkier T, Chia SK. LeVasseur N, et al. Among authors: feng x. Clin Breast Cancer. 2022 Jan;22(1):e74-e79. doi: 10.1016/j.clbc.2021.09.004. Epub 2021 Sep 17. Clin Breast Cancer. 2022. PMID: 34690081
18,229 results
You have reached the last available page of results. Please see the User Guide for more information.